HR
TAK icon

Howe & Rusling’s Takeda Pharmaceutical TAK Stock Holding History

Howe & Rusling’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$1K – 945
2022
Q3 		$1K Hold
100
– – ﹤0.01% 1010
2022
Q2 		$1K Hold
100
– – ﹤0.01% 1001
2022
Q1 		$1K Hold
100
– – ﹤0.01% 962
2021
Q4 		$1K Hold
100
– – ﹤0.01% 958
2021
Q3 		$2K Hold
100
– – ﹤0.01% 881
2021
Q2 		$2K Hold
100
– – ﹤0.01% 836
2021
Q1 		$2K Buy
+100
New +$1.8K ﹤0.01% 847

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return